Pyridam Farma Tbk (PYFA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pyridam Farma Tbk (PYFA) has a cash flow conversion efficiency ratio of -0.182x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-155.84 Billion ≈ $-9.13 Million USD) by net assets (Rp856.41 Billion ≈ $50.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pyridam Farma Tbk (PYFA) liquidity interval to measure how many days the company can operate on defensive assets alone.
Pyridam Farma Tbk - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Pyridam Farma Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Pyridam Farma Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pyridam Farma Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Xinhua Pharmaceutical Company Limited
F:XIN
|
0.010x |
|
Benchmark Holdings Plc
LSE:BMK
|
0.036x |
|
PT Net Visi Media Tbk
JK:NETV
|
-0.096x |
|
IKIO Lighting Limited
NSE:IKIO
|
0.008x |
|
RCM Technologies Inc
NASDAQ:RCMT
|
-0.030x |
|
Lindsell Train Investment Trust Plc
LSE:LTI
|
0.018x |
|
Dwi Guna Laksana Tbk PT
JK:DWGL
|
-0.045x |
|
Salasar Techno Engineering Limited
NSE:SALASAR
|
0.024x |
Annual Cash Flow Conversion Efficiency for Pyridam Farma Tbk (2001–2024)
The table below shows the annual cash flow conversion efficiency of Pyridam Farma Tbk from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see Pyridam Farma Tbk market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp1.04 Trillion ≈ $60.91 Million |
Rp-141.04 Billion ≈ $-8.26 Million |
-0.136x | +53.41% |
| 2023-12-31 | Rp357.06 Billion ≈ $20.92 Million |
Rp-103.98 Billion ≈ $-6.09 Million |
-0.291x | -146.80% |
| 2022-12-31 | Rp442.36 Billion ≈ $25.92 Million |
Rp275.24 Billion ≈ $16.13 Million |
0.622x | +162.65% |
| 2021-12-31 | Rp167.10 Billion ≈ $9.79 Million |
Rp39.59 Billion ≈ $2.32 Million |
0.237x | +3257.54% |
| 2020-12-31 | Rp157.63 Billion ≈ $9.24 Million |
Rp1.11 Billion ≈ $65.17K |
0.007x | -95.00% |
| 2019-12-31 | Rp124.73 Billion ≈ $7.31 Million |
Rp17.61 Billion ≈ $1.03 Million |
0.141x | +855.30% |
| 2018-12-31 | Rp118.93 Billion ≈ $6.97 Million |
Rp1.76 Billion ≈ $102.99K |
0.015x | -43.44% |
| 2017-12-31 | Rp108.86 Billion ≈ $6.38 Million |
Rp2.84 Billion ≈ $166.67K |
0.026x | -2.49% |
| 2016-12-31 | Rp105.51 Billion ≈ $6.18 Million |
Rp2.83 Billion ≈ $165.67K |
0.027x | -82.72% |
| 2015-12-31 | Rp101.22 Billion ≈ $5.93 Million |
Rp15.70 Billion ≈ $919.95K |
0.155x | +922.72% |
| 2014-12-31 | Rp97.10 Billion ≈ $5.69 Million |
Rp1.47 Billion ≈ $86.29K |
0.015x | +124.32% |
| 2013-12-31 | Rp93.90 Billion ≈ $5.50 Million |
Rp-5.86 Billion ≈ $-343.18K |
-0.062x | -1119.11% |
| 2012-12-31 | Rp87.71 Billion ≈ $5.14 Million |
Rp-448.72 Million ≈ $-26.29K |
-0.005x | -124.97% |
| 2011-12-31 | Rp82.40 Billion ≈ $4.83 Million |
Rp1.69 Billion ≈ $98.91K |
0.020x | -83.41% |
| 2010-12-31 | Rp77.23 Billion ≈ $4.53 Million |
Rp9.54 Billion ≈ $558.89K |
0.124x | +79.66% |
| 2009-12-31 | Rp73.03 Billion ≈ $4.28 Million |
Rp5.02 Billion ≈ $294.17K |
0.069x | +546.38% |
| 2008-12-31 | Rp69.25 Billion ≈ $4.06 Million |
Rp736.54 Million ≈ $43.16K |
0.011x | -81.42% |
| 2007-12-31 | Rp66.94 Billion ≈ $3.92 Million |
Rp3.83 Billion ≈ $224.58K |
0.057x | +236.74% |
| 2006-12-31 | Rp65.20 Billion ≈ $3.82 Million |
Rp-2.73 Billion ≈ $-159.96K |
-0.042x | -268.82% |
| 2005-12-31 | Rp63.47 Billion ≈ $3.72 Million |
Rp1.57 Billion ≈ $92.24K |
0.025x | -66.04% |
| 2004-12-31 | Rp62.14 Billion ≈ $3.64 Million |
Rp4.54 Billion ≈ $265.94K |
0.073x | +34.81% |
| 2003-12-31 | Rp60.71 Billion ≈ $3.56 Million |
Rp3.29 Billion ≈ $192.72K |
0.054x | -27.58% |
| 2002-12-31 | Rp60.09 Billion ≈ $3.52 Million |
Rp4.50 Billion ≈ $263.39K |
0.075x | +17.85% |
| 2001-12-31 | Rp60.52 Billion ≈ $3.55 Million |
Rp3.84 Billion ≈ $225.10K |
0.063x | -- |
About Pyridam Farma Tbk
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extra… Read more